Paolo Simioni
Overview
Explore the profile of Paolo Simioni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
321
Citations
4369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willems R, Zanetto A, Campello E, de Simone I, Bulato C, Konings J, et al.
J Thromb Haemost
. 2025 Mar;
PMID: 40056990
Background: Patients with cirrhosis develop multiple hemostatic alterations. Although fibrinolysis is also affected by liver disease, studies have produced conflicting results, highlighting the need for a reliable fibrinolysis assay. Assessing...
2.
Vergadoro M, Spiezia L, Zanetto A, Zola E, Simioni P
Alcohol Alcohol
. 2025 Mar;
60(2).
PMID: 40052444
Aims And Methods: Hazardous alcohol use poses an increasing public health issue worldwide and it manifests as excessive consumption (acute or chronic), which may lead to addiction. The risk of...
3.
Zanetto A, Campello E, Senzolo M, Simioni P
J Hepatol
. 2025 Feb;
PMID: 39983839
No abstract available.
4.
Napolitano A, Spiezia L, Biolo M, Radu C, Toffanin S, Campello E, et al.
Semin Thromb Hemost
. 2025 Jan;
PMID: 39884292
Anti-platelet factor 4 (PF4) antibody-mediated disorders are a heterogeneous group of diseases characterized by the presence of highly pathogenic immunoglobulins G directed against PF4 and/or PF4/heparin complexes. These antibodies are...
5.
Zanetto A, Vitale A, Pelizzaro F, Simeon V, Campello E, Turco L, et al.
United European Gastroenterol J
. 2025 Jan;
PMID: 39846484
Background & Aims: Venous thromboembolism (VTE) is a recognized complication of acutely ill patients, but its incidence and risk factors in those with cirrhosis are uncertain. Methods: We retrospectively studied...
6.
Mazzitelli M, Sartori M, Scaglione V, Lucente F, Gerosa G, Leonardi A, et al.
Medicina (Kaunas)
. 2025 Jan;
60(12.
PMID: 39768871
Almost 25 years have now passed since the first identification of (). It can cause infections both in immunocompetent and immunocompromised hosts. However, it has been rarely described as an...
7.
Campello E, Zanetto A, Prokopenko Y, Ilich A, Moonla C, Bulato C, et al.
Thromb Haemost
. 2024 Dec;
PMID: 39719151
Background: Portal vein system-specific risk factors contributing to portal vein thrombosis in cirrhosis are poorly investigated. Aim: This study aimed to quantify contact system and intrinsic pathway activation in the...
8.
Simioni P, Cipriano A, DAngelo A, Giannasi G, Ricci G, Campello E, et al.
Thromb Res
. 2024 Dec;
245:109241.
PMID: 39700713
No abstract available.
9.
Zanetto A, Campello E, Bulato C, Willems R, Konings J, Roest M, et al.
J Hepatol
. 2024 Dec;
PMID: 39672204
Background & Aims: The clinical utility of thrombomodulin-modified thrombin generation (TM-TG) in cirrhosis is uncertain. We conducted a prospective study to evaluate the prognostic value of TM-TG in cirrhosis. Methods:...
10.
Ferrarese A, Zanaga P, Battistella S, Zanella S, Zappitelli T, Boldrin C, et al.
Aliment Pharmacol Ther
. 2024 Dec;
61(4):667-674.
PMID: 39655800
Background: Screening programmes for the detection of patients with hepatitis C virus (HCV) and positive viral load have been developed in many countries to achieve the World Health Organization's goal...